Cerebrovascular Disease without Acute Cerebral Symptom (ICD-11: 8B21)

1. Introduction

Cerebrovascular disease without acute cerebral symptoms represents a diagnostic category of extreme clinical importance that was significantly expanded and refined in ICD-11. This classification encompasses vascular neurological conditions that, although not manifesting as dramatic acute events, carry substantial consequences for cerebral function and patient prognosis.

Unlike traditional stroke, which presents with sudden and evident neurological symptoms, cerebrovascular diseases without acute symptoms include silent cerebral infarcts, cerebral microhemorrhages, and white matter abnormalities of vascular origin. These conditions are frequently discovered incidentally during neuroimaging examinations performed for other reasons, but their presence should not be underestimated or ignored.

The clinical importance of these conditions lies in the fact that, despite being "silent" from the perspective of acute symptoms, they have documented impact on cognition, gait, balance, urinary function, and risk of future vascular events. Scientific studies clearly demonstrate that patients with these alterations present greater risk of developing vascular dementia, progressive cognitive decline, and other cerebrovascular events.

Correct coding of this condition is critical for several reasons: it allows formal recognition of a condition that requires preventive management, facilitates appropriate patient follow-up, justifies interventions for risk factor control, and contributes to more precise epidemiological data. Furthermore, the identification and appropriate coding of these conditions can prevent progression to more severe cerebrovascular events.

2. Correct ICD-11 Code

Code: 8B21

Description: Cerebrovascular disease without acute cerebral symptom

Parent category: Cerebrovascular diseases

Official definition and clinical context:

This code was established in ICD-11 based on substantial scientific evidence demonstrating that silent cerebral infarcts carry important consequences on brain function, including cognition, gait and balance, in addition to significant prognostic implications. Although the effects of specific therapies have not yet been completely demonstrated, assessment and control of risk factors should be applied for preventive purposes.

Cerebral microhemorrhages were recognized more recently as clinically relevant entities. Although scientific evidence regarding their clinical implications and prognosis is not yet as well documented as for silent cerebral infarcts, the current state of knowledge justified their inclusion in this block, rather than considering them only incidental findings.

Since ICD-10, significant progress has been made in the field of white matter abnormalities associated with vascular disease. Other terms used include leukoaraiosis and ischemic white matter abnormalities. It has been demonstrated that the presence of white matter abnormalities has prognostic implications in cerebrovascular disease and has strong links with cognitive impairment, dementia, and non-focal neurological symptoms such as gait abnormalities, balance disorders, and urinary dysfunction.

It is important to emphasize that these entities do not represent a "stroke" in the traditional sense, but conditions that require medical attention and appropriate preventive management.

3. When to Use This Code

The code 8B21 should be used in specific clinical situations where there is evidence of cerebrovascular disease without acute manifestation. Here are the detailed practical scenarios:

Scenario 1: Silent Cerebral Infarcts Identified on Neuroimaging

A 65-year-old patient undergoes brain magnetic resonance imaging for investigation of chronic headache. The examination reveals multiple areas of hyperintensity on T2/FLAIR in the periventricular and subcortical white matter, compatible with old lacunar infarcts, without the patient reporting a history of previous acute neurological events. The current neurological examination is normal or presents only subtle alterations. This is the classic scenario for using code 8B21, as there is clear evidence of cerebrovascular disease without associated acute symptoms.

Scenario 2: Cerebral Microhemorrhages on Routine Examination

During preoperative evaluation, a 58-year-old female patient with arterial hypertension undergoes brain magnetic resonance imaging that demonstrates multiple cerebral microhemorrhages (microbleeds) on magnetic susceptibility sequences (SWI or GRE), located in the basal ganglia and subcortical region. The patient does not present acute neurological symptoms and has never been diagnosed with stroke. Code 8B21 is appropriate because microhemorrhages represent cerebrovascular disease without acute manifestation.

Scenario 3: Leukoaraiosis or White Matter Abnormalities

A 70-year-old patient seeks care for progressive mild cognitive decline and subtle gait alterations. Brain magnetic resonance imaging shows extensive leukoaraiosis (diffuse abnormalities of periventricular and deep white matter) without evidence of acute infarcts or recent hemorrhages. The patient has vascular risk factors such as hypertension and diabetes. Code 8B21 is appropriate because white matter alterations are of presumed vascular origin and do not represent an acute event.

Scenario 4: Incidental Findings in Patients with Risk Factors

During investigation of positional vertigo, a 62-year-old patient with diabetes mellitus and hypertension undergoes magnetic resonance imaging that identifies small areas of gliosis and old lacunar infarcts in the basal ganglia, without correlation with current or previous acute symptomatology. This incidental finding of cerebrovascular disease without acute symptoms justifies the use of code 8B21 and indicates the need for rigorous control of risk factors.

Scenario 5: Follow-up of Patients with Small Vessel Disease

A patient under neurological follow-up for memory complaints undergoes serial neuroimaging that demonstrates progression of cerebral microvascular alterations, including increased white matter hyperintensities and new asymptomatic lacunar infarcts. There were no acute events between examinations. Code 8B21 appropriately documents progressive cerebrovascular disease without acute symptoms.

Scenario 6: Evaluation in Patients with Cognitive Decline

A 68-year-old patient is referred for evaluation of progressive cognitive decline. The investigation includes magnetic resonance imaging that reveals significant burden of cerebral small vessel disease, with multiple chronic lacunar infarcts, microhemorrhages, and moderate to severe leukoaraiosis. There is no history of acute vascular events. Code 8B21 is appropriate because cerebrovascular disease is contributing to the clinical presentation without having manifested as acute events.

4. When NOT to Use This Code

It is fundamental to understand exclusion situations to avoid inadequate coding:

Exclusion for Transient Ischemic Attack (TIA):

When the patient presents with acute neurological symptoms that completely resolve in less than 24 hours, even if neuroimaging does not show acute infarction, the appropriate code is not 8B21. TIA represents an acute symptomatic event and should be coded appropriately, even if transient.

Exclusion for Ischemic Stroke:

If there is evidence of acute cerebral infarction with corresponding neurological symptoms, regardless of severity, the correct code is not 8B21. Even small infarcts that cause minimal acute symptoms (such as mild dysarthria or transient weakness) should be coded as ischemic stroke, not as cerebrovascular disease without acute symptoms.

Exclusion for Intracerebral Hemorrhage:

Any symptomatic cerebral hemorrhage, acute or subacute, should be coded as intracerebral hemorrhage, not as 8B21. Even if the hemorrhage is small, if it caused identifiable acute symptoms, it does not fall into this category.

Exclusion for Subarachnoid Hemorrhage:

Presence of blood in the subarachnoid space, even in small amounts, if associated with acute symptoms (sudden headache, altered consciousness), excludes the use of code 8B21.

Exclusion for Undetermined Type Stroke:

When there is evidence of acute stroke, but it is not possible to determine whether it is ischemic or hemorrhagic (for example, due to neuroimaging limitations or clinical presentation), the specific code for undetermined stroke should be used, not 8B21.

Important Differentiation:

Code 8B21 is exclusive for situations where there are NO acute neurological symptoms attributable to the identified cerebrovascular lesion. The presence of any acute symptomatology, even if minimal or transient, excludes this code. Furthermore, progressive cognitive changes or chronic neurological symptoms (such as gait disturbances) are not considered "acute symptoms" and do not exclude the use of this code.

5. Coding Step by Step

Step 1: Assess Diagnostic Criteria

Diagnosis confirmation:

The diagnosis of cerebrovascular disease without acute cerebral symptoms requires mandatory confirmation by neuroimaging. Diagnostic methods include:

Cerebral magnetic resonance imaging: It is the method of choice, especially with FLAIR sequences for white matter, DWI for acute infarcts (which should be absent), GRE or SWI for microhemorrhages, and T1/T2 for general structural evaluation.
Cerebral computed tomography: Can identify old lacunar infarcts and leukoaraiosis, but is less sensitive than magnetic resonance imaging for subtle white matter changes and microhemorrhages.

Essential criteria:

Presence of cerebral vascular changes on neuroimaging (silent infarcts, microhemorrhages, or leukoaraiosis)
Absence of acute neurological symptoms corresponding to identified lesions
Exclusion of other non-vascular causes for identified changes

Necessary complementary evaluations:

Detailed neurological clinical evaluation to document absence of acute deficits
Careful clinical history to exclude previously unrecognized acute events
Evaluation of cardiovascular risk factors
Cognitive evaluation may be appropriate, as these lesions frequently associate with cognitive decline

Step 2: Check Specifiers

Characteristics of silent cerebrovascular disease:

Type of lesion: Lacunar infarcts, microhemorrhages, leukoaraiosis, or combination
Location: Periventricular white matter, deep, subcortical, basal ganglia
Extension: Focal, multifocal, or diffuse
Disease burden: Mild, moderate, or severe (based on visual scales such as Fazekas for white matter)

Severity:

Severity is not classified by acute symptomatology (which is absent), but by the extent of changes on neuroimaging and the impact on chronic functional status (cognition, gait, balance).

Duration:

By definition, these are chronic or old subacute changes. The presence of acute lesions (such as diffusion restriction on DWI) suggests recent event and may not be appropriate for this code if there is clinical correlation.

Step 3: Differentiate from Other Codes

Differentiation from Intracranial Hemorrhage:

Acute intracranial hemorrhage presents with recent blood identifiable on neuroimaging and typically causes acute symptoms such as sudden headache, altered consciousness, focal neurological deficits. Code 8B21 may include old microhemorrhages (residual hemosiderin), but not acute or symptomatic subacute hemorrhages.

Differentiation from Cerebral Ischemia:

Acute cerebral ischemia manifests with sudden neurological symptoms and presents with diffusion restriction on magnetic resonance imaging. Code 8B21 is used for old, scarred infarcts with no correlation to acute events. The key difference is the presence or absence of acute symptoms and signs of active ischemia on neuroimaging.

Differentiation from Undetermined Stroke (8B20):

Code 8B20 is used when there is evidence of acute cerebrovascular accident with corresponding symptoms, but it is not possible to determine whether it is ischemic or hemorrhagic. The fundamental difference is that 8B20 requires acute symptoms, while 8B21 specifically excludes acute symptoms. If there is doubt about the nature of acute stroke, use 8B20; if there are no acute symptoms but there are chronic vascular changes, use 8B21.

Step 4: Necessary Documentation

Checklist of mandatory information:

[ ] Detailed description of neuroimaging findings
[ ] Type of examination performed and date
[ ] Location and characteristics of vascular lesions
[ ] Explicit documentation of absence of acute neurological symptoms
[ ] Relevant clinical history, including vascular risk factors
[ ] Current neurological examination
[ ] Evaluation of cognitive function, gait, and balance, if altered
[ ] Exclusion of non-vascular differential diagnoses

Appropriate record:

"Cerebral magnetic resonance imaging [date] demonstrates [description of lesions: lacunar infarcts, microhemorrhages, leukoaraiosis]. Patient with no history of acute neurological events. Current neurological examination [describe]. Presence of risk factors: [list]. Diagnosis: Cerebrovascular disease without acute cerebral symptoms (ICD-11: 8B21). Management: strict control of cardiovascular risk factors, neurological follow-up."

6. Complete Practical Example

Clinical Case:

A 67-year-old male patient seeks neurological care referred by his primary care physician due to complaints of progressive memory loss over the past two years, reported mainly by his wife. The memory loss involves recent appointments, conversations, and locating objects. He denies episodes of acute confusion, altered consciousness, or focal neurological symptoms. The family also notes that the patient presents with slowed gait and greater caution when walking, with occasional episodes of imbalance, without falls.

Past Medical History:

Arterial hypertension for 15 years, with irregular treatment. Type 2 diabetes mellitus for 10 years, with suboptimal glycemic control. Dyslipidemia under treatment. Smoking history of 30 pack-years, quit 5 years ago. Denies previous history of stroke, transient ischemic attack, or other acute neurological events.

Physical Examination:

Blood pressure: 152/94 mmHg. Cardiovascular and pulmonary examination without abnormalities. Neurological examination: patient alert and oriented, with mild difficulty in word retrieval. Cranial nerves without abnormalities. Muscle strength globally preserved. Sensation without deficits. Deep reflexes symmetric and present. Pathological reflexes absent. Gait with widened base, short steps, slowed, without asymmetries. Balance impaired on sensitized Romberg test.

Cognitive Assessment:

Mini-Cog State Examination: 24/30 points (loss in temporal orientation, recall memory, and attention/calculation). Clock drawing test with executive difficulties.

Neuroimaging:

Brain magnetic resonance imaging performed demonstrates:

Multiple areas of hyperintensity on T2/FLAIR in periventricular and deep white matter, bilateral and symmetric, confluent in periventricular regions (leukoaraiosis grade 3 by Fazekas scale)
Five small chronic lacunar lesions (4-8 mm) in basal ganglia and corona radiata, bilateral, with hypointensity on T1 and hyperintensity on T2
Multiple foci of hypointensity on GRE sequence in basal ganglia and subcortical region, compatible with microhemorrhages (approximately 12 lesions)
Absence of diffusion restriction (no acute infarcts)
Mild cortical atrophy for age
Absence of masses, acute hemorrhages, or other structural lesions

Complementary Exams:

Complete blood count, renal function, electrolytes, liver and thyroid function within normal limits. Glycated hemoglobin: 8.2%. Lipid profile: LDL 145 mg/dL. Vitamin B12 and folic acid normal. Syphilis serology negative.

Diagnostic Reasoning:

The patient presents with progressive cognitive decline and gait disturbances, associated with multiple poorly controlled cardiovascular risk factors. Neuroimaging demonstrates substantial burden of small vessel cerebrovascular disease, including chronic lacunar infarcts, microhemorrhages, and extensive leukoaraiosis. There is no evidence of acute infarcts or recent hemorrhages. The patient denies and there is no documentation of previous acute neurological events.

The cognitive and gait alterations are compatible with the pattern of chronic small vessel cerebrovascular disease, but do not represent acute symptoms. The condition is progressive and insidious, not sudden. Therefore, this is cerebrovascular disease without acute cerebral symptom, with chronic clinical manifestations secondary to the cumulative burden of vascular lesions.

Step-by-Step Coding:

Criteria Analysis:

✓ Presence of cerebral vascular alterations confirmed by high-quality neuroimaging
✓ Multiple types of lesions: lacunar infarcts, microhemorrhages, and leukoaraiosis
✓ Documented absence of acute neurological symptoms
✓ Absence of acute infarcts on neuroimaging (no diffusion restriction)
✓ Presence of vascular risk factors
✓ Chronic clinical manifestations compatible with cerebrovascular disease (cognition and gait)

Code Selected: 8B21 - Cerebrovascular disease without acute cerebral symptom

Complete Justification:

Code 8B21 is most appropriate because the patient presents with unequivocal evidence of extensive cerebrovascular disease on neuroimaging, without history or documentation of acute neurological events. The lesions identified (lacunar infarcts, microhemorrhages, and leukoaraiosis) are all chronic or old, without signs of acute activity. Although the patient presents with neurological symptoms (cognitive decline and gait alterations), these are chronic and progressive manifestations of cumulative cerebrovascular disease, not acute symptoms.

This code not only adequately documents the patient's condition but also justifies and emphasizes the need for rigorous control of cardiovascular risk factors for prevention of disease progression and future acute events.

Applicable Complementary Codes:

Code for vascular dementia or vascular cognitive impairment (if applicable by complete classification)
Codes for risk factors: arterial hypertension, diabetes mellitus, dyslipidemia
Code for gait disturbance (if additional coding is necessary)

Management:

Rigorous control of cardiovascular risk factors (optimization of antihypertensives, glycemic control, statin therapy), antiplatelet therapy, regular neurological follow-up, serial cognitive assessment, rehabilitation for gait and balance, and guidance for fall prevention.

7. Related Codes and Differentiation

Within the Same Category:

Intracranial Hemorrhage:

When to use vs. 8B21: Use the intracranial hemorrhage code when there is evidence of acute or subacute bleeding in the cerebral parenchyma, ventricular spaces, or meninges, especially if associated with acute symptoms such as sudden headache, altered consciousness, focal neurological deficits, or seizures. Use 8B21 when there are only old microhemorrhages (hemosiderin deposits) without active hemorrhage and without acute symptoms.

Main difference: Intracranial hemorrhage refers to acute or recent bleeding with corresponding clinical manifestation, while 8B21 may include evidence of old microhemorrhages without current hemorrhagic activity and without acute symptoms.

Cerebral Ischemia:

When to use vs. 8B21: Use the cerebral ischemia code when there is evidence of acute cerebral infarction with corresponding neurological symptoms, such as hemiparesis, aphasia, visual disturbance, ataxia, or other focal deficits of sudden onset. Neuroimaging typically shows diffusion restriction indicating acute ischemia. Use 8B21 when there are only old scarred infarcts without correlation with acute events.

Main difference: Cerebral ischemia implies an acute symptomatic event with active ischemic injury, while 8B21 refers to sequelae of vascular events that did not cause recognizable acute symptoms or to truly silent infarcts.

Stroke of Unknown Type, Ischemic or Hemorrhagic (8B20):

When to use vs. 8B21: Use 8B20 when there is clear evidence of acute stroke with corresponding neurological symptoms, but it is not possible to determine whether the mechanism is ischemic or hemorrhagic (for example, due to neuroimaging limitations, ambiguous clinical presentation, or lack of adequate tests). Use 8B21 when there are no acute symptoms, regardless of whether the lesions can be characterized as ischemic or hemorrhagic.

Main difference: The fundamental distinction is the presence or absence of acute neurological symptoms. Code 8B20 requires acute symptoms with uncertainty about the type of stroke; code 8B21 specifically excludes acute symptoms, regardless of lesion characterization.

Differential Diagnoses:

Multiple Sclerosis:

May present with white matter lesions on neuroimaging, but typically with different distribution (periventricular perpendicular to the corpus callosum—"Dawson's fingers," posterior fossa, spinal cord), in younger patients, with history of relapses and remissions. The presence of oligoclonal bands in cerebrospinal fluid and absence of vascular risk factors help with differentiation.

Leukoencephalopathy from Demyelinating Diseases:

Other demyelinating diseases may cause white matter changes, but generally with specific patterns, distinct clinical history, and absence of vascular risk factors.

CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy):

It is a genetic cause of small vessel cerebrovascular disease that may present similarly. Positive family history, early onset (before age 50), migraine with aura, and characteristic magnetic resonance imaging changes (involvement of anterior temporal poles and external capsule) suggest CADASIL. Confirmation by genetic testing or skin biopsy.

Fabry Disease:

X-linked lysosomal storage disease that can cause small vessel cerebrovascular disease. Systemic manifestations (angiokeratomas, acroparesthesias, cornea verticillata, cardiomyopathy, renal disease) and family history suggest the diagnosis.

Toxic or Metabolic Leukoencephalopathy:

Exposure to toxins (such as carbon monoxide, methanol, radiation) or metabolic disorders (such as reversible posterior leukoencephalopathy) can cause white matter changes, but generally with history of exposure or specific predisposing condition.

8. Differences with ICD-10

Equivalent ICD-10 code:

In ICD-10, there was no specific equivalent code for "cerebrovascular disease without acute cerebral symptom" as a unified entity. The conditions now included in ICD-11 code 8B21 were often coded in a fragmented or imprecise manner:

I67.8 (Other specified cerebrovascular diseases) was frequently used for leukoaraiosis or nonspecific changes
I69 (Sequelae of cerebrovascular disease) could be used for old infarcts, but implied a known previous acute event
Often, these conditions were not adequately coded or were recorded only as incidental findings without a specific code

Main changes in ICD-11:

Formal recognition: ICD-11 formally recognizes silent cerebrovascular diseases as distinct clinical entities that deserve specific coding, reflecting scientific progress in understanding their clinical importance.
Inclusion of multiple entities: Code 8B21 encompasses silent cerebral infarcts, cerebral microhemorrhages, and white matter abnormalities of vascular origin (leukoaraiosis) in a coherent category, recognizing that they frequently coexist and share clinical implications.
Emphasis on prevention: The explicit definition emphasizes the importance of risk factor assessment and management, even in the absence of proven specific therapies, highlighting the preventive role.
Clear distinction from stroke: ICD-11 makes explicit that these entities do not represent "stroke" in the traditional sense, avoiding stigmatization and diagnostic confusion.
Evidence-based: The inclusion of these conditions reflects accumulated scientific evidence regarding their functional consequences (cognition, gait, balance) and prognostic implications.

Practical impact of these changes:

The creation of code 8B21 has significant practical impacts:

Better documentation: Allows precise documentation of previously undercoded or uncoded conditions
Justification for interventions: Provides formal basis for justifying risk factor management and follow-up
Research and epidemiology: Facilitates epidemiological studies and research on these conditions
Clinical recognition: Increases recognition of the clinical importance of "silent" findings on neuroimaging
Structured prevention: Promotes systematic preventive approach in patients with asymptomatic cerebrovascular disease
Reduction of ambiguity: Eliminates doubts about how to code incidental vascular findings on neuroimaging

9. Frequently Asked Questions

1. How is cerebrovascular disease without acute cerebral symptoms diagnosed?

Diagnosis is made through neuroimaging, preferably brain magnetic resonance imaging, which identifies vascular alterations such as old lacunar infarcts, microhemorrhages, or leukoaraiosis. It is essential to document the absence of acute neurological symptoms corresponding to these lesions. Complete clinical evaluation, including detailed history and neurological examination, is fundamental to confirm that there were no recognizable acute events. In many cases, these alterations are discovered incidentally during examinations performed for other reasons, such as investigation of headache, vertigo, or preoperative evaluation.

2. Do patients with this diagnosis need treatment?

Although there are no proven specific therapies to reverse already established lesions, treatment is fundamental and focuses on prevention. Management includes strict control of cardiovascular risk factors: optimization of arterial hypertension treatment, adequate glycemic control in diabetics, use of statins for dyslipidemia, smoking cessation, and control of other modifiable factors. Platelet antiaggregation may be considered in many cases. Additionally, interventions to preserve cognitive function, rehabilitation for gait and balance, and fall prevention are important components of management.

3. Is treatment available in public health systems?

Interventions for controlling cardiovascular risk factors (antihypertensive, antidiabetic, statin, and platelet antiaggregant medications) are generally available in public health systems in most countries. Neurological evaluation and neuroimaging examinations are also usually accessible, although there may be waiting lists in some systems. Rehabilitation services and multidisciplinary follow-up may have variable availability depending on local health infrastructure.

4. How long does treatment last?

Management of cerebrovascular disease without acute cerebral symptoms is generally long-term or lifelong. Control of cardiovascular risk factors should be maintained continuously to prevent disease progression and occurrence of acute events. Regular neurological follow-up is recommended, with frequency varying according to the severity of alterations and presence of chronic symptoms. Follow-up neuroimaging may be performed periodically to assess progression, usually at intervals of one to three years, depending on the individual case.

5. Can this code be used in medical certificates?

Yes, code 8B21 can and should be used in medical documentation, including certificates when appropriate. However, it is important to contextualize adequately. This diagnosis by itself does not necessarily imply incapacity for work or other activities, unless chronic manifestations (such as significant cognitive decline or important gait alterations) cause functional limitation. Documentation should be clear about the nature of the condition (it is not an acute "stroke" or "CVA") and about any functional limitations present.

6. What is the difference between this diagnosis and a stroke?

The fundamental difference is that cerebrovascular accident (CVA) manifests with acute and sudden neurological symptoms (such as weakness on one side of the body, difficulty speaking, visual loss, altered consciousness), while cerebrovascular disease without acute cerebral symptoms does not cause recognizable acute symptoms. The lesions in code 8B21 may have occurred in a truly silent manner or may be old sequelae of events that were not recognized at the time. It is important to clarify to patients that, although there is cerebral vascular disease, they did not have a "stroke" in the traditional sense.

7. Do patients with this diagnosis have a higher risk of developing stroke in the future?

Yes, the presence of silent cerebrovascular disease is associated with higher risk of future acute cerebrovascular events, including ischemic and hemorrhagic stroke. This is one of the main reasons why strict control of risk factors is so important. Studies demonstrate that patients with silent infarcts, microhemorrhages, or significant leukoaraiosis have increased risk of symptomatic stroke, cognitive decline, and dementia. Regular follow-up and adherence to preventive treatment are essential to minimize these risks.

8. Can cognitive alterations associated with this diagnosis progress to dementia?

Yes, there is substantial scientific evidence that small vessel cerebrovascular disease, even when silent, is strongly associated with the development of vascular cognitive impairment and vascular dementia. Progression depends on several factors, including the extent of lesions, control of risk factors, and occurrence of new vascular events. Therefore, strict control of cardiovascular risk factors serves not only to prevent stroke, but also to preserve cognitive function. Periodic cognitive evaluation is recommended to detect early decline and implement appropriate interventions.

Conclusion:

ICD-11 code 8B21 - Cerebrovascular disease without acute cerebral symptoms - represents an important advance in the recognition and classification of cerebral vascular conditions that, although they do not manifest as dramatic acute events, have significant consequences for brain function and patient prognosis. Appropriate coding of these conditions not only improves medical documentation but also emphasizes the importance of preventive management, justifies interventions for risk factor control, and contributes to better epidemiological understanding of these diseases. Healthcare professionals should be familiar with this code and its precise indications to ensure appropriate care for patients with silent cerebrovascular disease.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Cerebrovascular disease without acute cerebral symptom

Share